APA (7th ed.) Citation

SH, H., E, B., & M, N. (2017). Comparative risk of major bleeding with new oral anticoagulants (NOACs) and phenprocoumon in patients with atrial fibrillation: A post-marketing surveillance study. Clinical research in cardiology : official journal of the German Cardiac Society, 106(8), 618. https://doi.org/10.1007/s00392-017-1098-x

Chicago Style (17th ed.) Citation

SH, Hohnloser, Basic E, and Nabauer M. "Comparative Risk of Major Bleeding with New Oral Anticoagulants (NOACs) and Phenprocoumon in Patients with Atrial Fibrillation: A Post-marketing Surveillance Study." Clinical Research in Cardiology : Official Journal of the German Cardiac Society 106, no. 8 (2017): 618. https://doi.org/10.1007/s00392-017-1098-x.

MLA (9th ed.) Citation

SH, Hohnloser, et al. "Comparative Risk of Major Bleeding with New Oral Anticoagulants (NOACs) and Phenprocoumon in Patients with Atrial Fibrillation: A Post-marketing Surveillance Study." Clinical Research in Cardiology : Official Journal of the German Cardiac Society, vol. 106, no. 8, 2017, p. 618, https://doi.org/10.1007/s00392-017-1098-x.